Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Drug Induced Liver Disease
How do you counsel patients on the use and risks of alternative medications and supplements given how prevalent and easily accessible they are to the average person and their risk of liver injury?
Related Questions
When do you pursue liver biopsy for assessment of DILI?
How would you approach the management of drug-induced autoimmune hepatitis compared to non-drug-induced autoimmune hepatitis?
How do you utilize the Sustained Alcohol Use Post-Liver Transplant (SALT) score on surveillance for alcohol use for patients after liver transplant?
Can fatty liver disease present with elevations in alkaline phosphatase without other liver enzyme elevations (AST and ALT)?
When giving albumin challenge, for acute kidney injury with suspected hepatorenal syndrome, do you administer a single dose daily or split the dose of albumin?
How do you differentiate primary from secondary iron overload?
When would you consider use of EUS guided liver biopsy over percutaneous and/or transjugular?
When treating fatty liver disease with resmetirom, how often should a FibroScan be repeated to assess treatment response?
What is your approach to the management of post-TIPS hepatic encephalopathy?
How do you decide between urgent early liver transplant listing versus a time-limited “watchful waiting” strategy in critically ill severe alcohol-associated hepatitis with some signs of potential hepatic recovery?
